Home About us Events Media data Subscribe Links News Email alert Search Contact us Blog  
Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
  
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 		 

Click here to view
our current issue
 
 

Moving Towards the Cost- Efficient Ex Vivo Production of Blood

Andy Wylde and Adrian Stacey at TAP Biosystems discuss how micro-bioreactors could soon be employed to produce red blood

Andy Wylde and Adrian Stacey, TAP Biosystems (June 2012)

Keywords: Ex vivo blood production Red blood cells Haematopoietic stem cells (HSCs) Automated micro-scale bioreactor

    View full article    |    Back to Bioprocessing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | caitlin@samedanltd.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |